Description
MK 677 (Ibutamoren) is a long-acting, selective ghrelin receptor agonist and growth hormone secretagogue studied in laboratory settings for its interaction with the ghrelin receptor and GH/IGF-1 signaling pathways.
Research literature has examined MK 677 for its ability to influence growth hormone release, insulin-like growth factor-1 activity, and related endocrine signaling markers. These mechanisms make it a compound of interest for controlled in-vitro and pre-clinical research involving metabolic, endocrine, and receptor-pathway analysis.
MK 677 is commonly referenced in studies exploring ghrelin receptor activation, somatotropic signaling, and modulation of growth hormone-related pathways. Its research profile is associated with investigation into receptor selectivity, signaling duration, and downstream biomarker activity.
Growth-Tech v2: Nano-K-677
Molecular Formula Derivative: C27H36N4O6S
Research Targets:
Ghrelin Receptor Activity
GH/IGF-1 Signaling
Endocrine Pathway Analysis
Growth-Tech v2: Nano-K-677 is supplied as a research compound for controlled laboratory study of ghrelin receptor activity and growth hormone secretagogue pathways.
This compound is provided with a focus on purity, stability, documentation, and research-use suitability. Batch documentation and quality records are available for research and reference purposes.
All products are supplied for controlled laboratory research purposes only. Product information is provided for research documentation, identification, and reference purposes.
Note: All compounds are supplied for controlled laboratory research purposes only. Product information on this site is provided for research documentation, identification, and reference purposes, and has not been reviewed by any regulatory body. These products are supplied only for controlled laboratory research and reference use. Please refer to our product use and disclaimer for more information.